Advancing Kratom Science and Regulation: A Comparative Framework With Cannabis

Area of Science:

• Pharmacology
• Ethnobotany
• Regulatory Science

Background:

• Kratom (Mitragyna speciosa) is a psychoactive botanical used in Southeast Asia and increasingly in the US for its analgesic, stimulant, and mood-altering effects.
• Limited scientific evidence exists, and commercial kratom products exhibit significant variability in composition and potency.
• Existing research highlights the need for standardized products and clear regulatory frameworks to assess kratom's therapeutic potential.

Purpose of the Study:

• To review current knowledge on kratom's pharmacology.
• To propose a research and regulatory strategy for evaluating kratom's therapeutic applications.
• To differentiate between whole leaf, enriched, and semi-synthetic kratom products regarding evidence standards and regulatory pathways.

Main Methods:

• Narrative review of existing literature on kratom's pharmacology and use.
• Analysis of lessons learned from cannabis research and regulation.
• Development of a proposed dual-track regulatory framework for kratom products.

Main Results:

• Kratom's effects are linked to its complex alkaloid profile, with significant differences between whole leaf and processed/synthetic forms.
• Chemically defined preparations, validated analytical methods, and human studies (PK/PD, abuse liability) are essential.
• A dual regulatory approach is proposed: enhanced standards for botanical products and conventional drug development for enriched/synthetic constituents.

Conclusions:

• Establishing distinct evidence standards for different kratom product types is necessary.
• A coordinated federal effort is required for product standardization, clinical trials, and comparative evaluations.
• Implementing a structured research and regulatory pathway can facilitate the examination of kratom's therapeutic applications while prioritizing public health and safety.